People talk about it as the sure way to control costs and give consumers the choice they seem to want. Are we being realistic?
Plans looking for a low-risk way to experiment with new benefit designs might start with the pharmacy benefit.
Society must realize that health care resources are limited and then must use them rationally. Fairly, too?
Companies are decreasing their share of premiums. It remains to be seen how this will affect workers’ health status.
A relatively new concept in strategic management provides a way to balance quality and customer satisfaction with costs and long-range goals
Back from obscurity, the Patients’ Bill of Rights is poised to become an issue in the presidential election — depending on whom you ask.
Departments
EDITOR’S MEMO
LEGISLATION & REGULATION
HMOs, medical associations, and pharmaceutical companies should all expect more scrutiny regarding how they play the political game.
COMPENSATION MONITOR
THE FORMULARY FILES
TOMORROW’S MEDICINE
The biotech field is booming and managed care is scrambling to level the playing field by creating competition.
MANAGED CARE OUTLOOK
News & Commentary
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.